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Objective: To evaluate acute and subacute toxicity of methanol extract of Terminalia
citrina leaves (family: Combretaceae) in Sprague Dawley rats.
Methods: The acute toxicity studies were conducted where the limit test dose of 3
200 mg/kg body weight used. Observations were made and recorded systemically on 1, 2,
4, 24 and 48 h after dose administration for behavior, breathing, cutaneous effects,
sensory nervous system response or gastrointestinal effects. For the subacute toxicity,
four groups of 10 female rats were received; distilled water (control), 250, 500 and
1000 mg/kg of extracts respectively every 24 h orally for 28 days.
Results: No signiﬁcant variation in the body and organ weights between the control and
the treated group was observed after 28 days of treatment. Haematological analysis and
biochemical parameters revealed no toxic effects of the extract. Pathologically, neither
gross abnormalities nor histopathological changes were observed. No mortality was
recorded in 28 days.
Conclusions: It was safer and non toxic to rats even at higher doses and therefore could
be well considered for further investigation for its medicinal and therapeutic efﬁcacy.1. Introduction
The usage of medicinal plants has a great importance from
ancient times[1], because plants produce a wide range of drugs to
widen the therapeutic arsenal[2,3]. However, during the past few
decades, traditional system of medicine has drawn tremendous
attention for in vivo studies[4] and for this reason, more
researches are carried out in order to determine the toxicity of
medicinal plants and their products. Toxicity is an expression
of being poisonous, indicating the state of adverse effects led
by the interaction between toxicants and cells. This
mechanism of action may vary depending on the cell
membrane and chemical properties of the toxicants. It may
occur within the cell membrane or on the cell surface or tissue
beneath as well as at the extracellular matrix. In most of the
cases vital organs such as liver and kidney are affected by the
toxicants[5].
Terminalia citrina [(T. citrina) (Bengali name: Haritaki;
family: Combretaceae)] is a deciduous tree wide spreadthroughout the forest of Gazipur, Tangail, Sylhet, Chittagong,
Rangamati and Chittagong hill tracts of Bangladesh. It is an
important medicinal plant having various ethno-
pharmacological uses. Different parts of the plant are used for
various ailments. The fruit is used in long-term fever, loss of
appetite and as sexual stimulant in Bangladesh [6]; diarrhea,
helminthes and other digestive disorders in Iran [7]. Its bark is
diuretic and cardio tonic[8]. Seed is used in stomach aches
and intestinal disease[9]. The plant is also used in asthma,
diarrhea, boils, burns, constipation, migraine, dental disease,
haemoptysis, dizziness, bleeding hemorrhoids, eye disease,
gastric hyperacidity, anemia, arthritis, hoarse voice,
dysentery, pyrexia, infections, traumatic cuts, cardiac
diseases, cough, hepatomegaly, urolithiasis and for life
longevity in Myanmar [10]. A detailed literature survey
revealed that seed of plant was reported to possess
antioxidant properties[11] and ﬁve tannins identiﬁed as
corilagin (1) (3), punicalagin (2) (4), 1,3,6-tri-O-galloyl-b-D-
glucopyranose (3) (5), chebulagic acid (4) (6), and 1,2,3,4,6-
penta-O-galloyl-b-D-glucopyranose (5) (7) was isolated from
methanol extract of fruit[12].
However, no detailed pharmacological study has been re-
ported in the literature. Therefore in the present investigation, we
aimed to investigate toxicity activities of T. citrina leaves forhts reserved.
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treat various ailments.
2. Materials and methods
2.1. Collection of plant material
T. citrina leaves were collected from Rangamati District,
Bangladesh during the month of May 2013. The plant was
identiﬁed and authenticated by Sardar Nasir Uddin, Senior
Scientiﬁc Ofﬁcer, Bangladesh National Herbarium Mirpur,
Dhaka and a voucher specimen (Accession No.: DACB 38094)
was deposited there for future reference.
2.2. Preparation of methanolic extract
The leaves of the plant were collected in fresh condition. The
dried and coarse powder (1000 g) was extracted with methanol
(4.0 L) in an air tight ﬂat bottomed container for 15 days at room
temperature with occasional stirring. The extract was then
ﬁltered through a cotton plug followed by a Whatman No. 1
ﬁlter paper. The ﬁltrate was concentrated using a rotary evapo-
rator at low temperature and pressure to afford crude methanol
extract (50 g).
2.3. Experimental animal
Eight-week old female albino rats (Rattus norvegicus:
Sprague-Dawley strain) weighing 110–140 g were used for the
present study. They were purchased and maintained in the ani-
mal house of Jahangirnagar University, Bangladesh for experi-
mental purpose. The animals were maintained under controlled
conditions of temperature (23 ± 2) C, humidity (50 ± 5)% and
12 h light–dark cycles. All the animals were acclimatized for
seven days before the study. The animals were randomized into
experimental and control groups and housed individually in
sanitized polypropylene cages containing sterile paddy husk as
bedding. They had free access to standard pellets as basal diet
and water ad libitum. Animals were habituated to laboratory
conditions for 48 h prior to experimental protocol to minimize if
any of non-speciﬁc stress. All experimental protocols were in
compliance with Dhaka University Ethics Committee on
Research in Animals as well as internationally accepted princi-
ples for laboratory animal use and care.
2.4. Phytochemical screening
The preliminary phytochemical group test was carried out by
following standard procedure[13].
2.5. Acute toxicity test
The acute toxicity of T. citrina methanolic extract was
determined in rats according to the method[14]. Rats fasted for
16 h were randomly divided into groups of ten rats per group.
Graded doses of the extract (200, 400, 800, 1600 and
3200 mg/kg p.o.) were separately administered to the rats in
each of the group by means of bulbed steel needle. All rats
were then allowed free access to food and water and observed
over a period of 48 h for signs of acute toxicity. The number
of deaths within this period was recorded.2.6. Subacute toxicity test
Sub-acute toxicity test was performed according to the World
Health Organization guideline[15] and the Organization of
Economic Co-operation and Development guideline 407 for
testing of chemicals[16].
The plant extract at the doses of 250, 500 and 1000 mg/kg
body weight were administered orally to 4 groups of ten female
rats respectively at every 24 h for 28 days and control received
vehicle at the same volume. The toxic manifestation such as
body weight, mortality, food and water intake was monitored.
After 28 days all surviving animals were fasted overnight and
anaesthetized with ether. The heparinized blood samples were
collected for determining hematological parameters and the
serum from non-heparinized blood was carefully collected for
determining clinical blood chemistry. Animals were sacriﬁced
after blood collection and the internal organs were removed and
weighed to determine the relative organ weights and observed
for gross lesions. The internal organs were preserved in 10%
buffered formaldehyde solution for histological examination.
2.6.1. Weekly body weight
The body weight of each rat was assessed using a sensitive
balance during the acclimatization period, once before
commencement of dosing, once weekly during the dosing period
and once on the day of sacriﬁce.
2.6.2. Mortality and clinical signs
During the four-week dosing period, all the animals were
observed daily for clinical signs and mortality patterns once before
dosing, immediately after dosing and up to 4 h after dosing[17]. On
29th day, the animals were anaesthetizedwith ketamine, bloodwas
collected by sino-orbital puncture and centrifuged for 30 min at
2000 r/min to separate serum for biochemical analysis. The liver
and kidney were excised immediately and thoroughly washed in
normal saline and weights were recorded.
2.6.3. Relative organ weight
On 29th day, all the animals were anaesthetized with keta-
mine. Organs namely, liver and kidneys were carefully dissected
out and weighed in grams. The relative organ weight of each
animal was then calculated as follows:
Relative organ weight = absolute organ weight (g) × 100/
body weight of rat on sacriﬁce day (g).
2.6.4. Hematological parameters
Estimation of hemoglobin (Hb) content (Sahli's hemoglo-
binometer), total white blood count (WBC), red blood cell
(RBC) and platelet count (Neubauer hemocytometer; Feinoptik,
Germany) was done using standard technique and differential
WBC count (neutrophil, eosinophil, basophil, lymphocyte and
monocyte) was done by Leishman's staining method. Mean cell
volume (MCV) indicated the volume of the average red cell in a
sample expressed in femtoliters (fL) and calculated by using the
formula: MCV = packed-cell volume/RBC × 10. Mean cell
hemoglobin (MCH) represents the absolute amount of Hb in the
average red cell in a sample in units of picogram per cell. The
MCH is calculated from the Hb and the RBC using the
following formula: MCH = (Hb × 10)/RBC. Mean corpuscular
hemoglobin concentration (MCHC) is the average Hb concen-
tration in the RBCs. The MCHC expressed as the amount of Hb
Table 2
Effect of T. citrina leaves on relative weight of liver and kidney (g/100 g
body weight).
Group Liver weight Kidney weight
Control 3.95 ± 0.83 0.89 ± 0.07
І 3.46 ± 0.45ns 0.84 ± 0.03ns
ІІ 3.24 ± 0.73ns 0.86 ± 0.04ns
ІІІ 2.94 ± 0.36ns 0.76 ± 0.02ns
Groups І–ІІІ methanolic extracts with doses (І: 250 mg/kg; ІІ: 500 mg/kg;
ІІІ: 1000 mg/kg); ns: Not signiﬁcant.
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MCHC = Hb/packed-cell volume. The hematocrit is the ratio of
RBCs to plasma and is expressed as a percentage of the whole
blood volume. The hematocrit is calculated from the RBC count
and the MCV as follows: hematocrit = (RBC × MCV)/10. Red
cell distribution width (RDW) is a measure of the heterogeneity
of the RBC population. The CELL-DYN 3700 system reports a
relative RDW equivalent to a CV in percent. The RDW is
derived from the RBC histogram using the width of the RBC
distribution at 50% of the peak height. The mean platelet volume
(MPV) is derived from the platelets histogram after the platelets
count has been determined. The MPV is expressed in fL. The
platelet distribution width (PDW) is a measure of the hetero-
geneity of the platelets population. It is expressed as the geo-
metric standard deviation. Erythrocyte sedimentation rate (ESR)
was determined by Westergren method. For the determination of
the bleeding time, modiﬁed procedure of Mohamed et al.[18] was
used. Clotting time test was performed using capillary tubes.
2.6.5. Biochemical estimations
Blood collected in non-heparinized tubes were than centri-
fuged at 3000 r/min for 10 min. The serum separated was
analyzed for various parameters such as creatinine, urea, was
done in Star 21 Plus, autoanalyzer by using the commercially
available standard kit (ERBA Diagnostics Mannheim GmbH,
Mannheim, Germany). Total protein content of serum was
estimated following modiﬁed biuret method using a standard kit
of Span Diagnostics Ltd., Dhaka, Bangladesh. Uric acid and
albumin were estimated using kit obtained from Lab-Care Di-
agnostics Pvt. Ltd., Dhaka, Bangladesh[19].
2.6.6. Histology of liver and kidney
Parafﬁn sections of liver and kidney were prepared, stained
with hematoxylin and eosin and processed for light microscope
following the technique[20].
2.7. Statistical analysis
All values were expressed as the mean ± SEM and the results
were analyzed statistically by One-way ANOVA followed by
Dunnett's t-test by using SPSS version 16. P < 0.05 compared to
standard was considered to be statistically signiﬁcant.
3. Results
3.1. Phytochemical screening
The phytochemical screening test showed the presence of
alkaloids, ﬂavonoids, tannins, reducing sugar and carbohydrates
in the leaves of T. citrina.Table 1
Effect of methanol extract of T. citrina leaves on body weight of rat at diffe
Group
Initial day 9th day
Control 114.10 ± 5.60 121.40 ± 5.78
І 117.40 ± 5.22ns 127.40 ± 6.24
ІІ 117.00 ± 5.97ns 124.60 ± 6.88
ІІІ 111.00 ± 4.24ns 116.80 ± 4.34
Groups І–ІІІ methanolic extracts with doses (І: 250 mg/kg; ІІ: 500 mg/kg;3.2. Acute toxicity test
In acute toxicity study, oral administration of graded doses
(200, 400, 800, 1600 and 3200 mg/kg p.o.) of the methanol
extract of T. citrina to rats showed no signiﬁcant changes in
behavior, breathing, cutaneous effects, sensory nervous system
responses or gastrointestinal effects during the observation
period. No mortality or any toxic reaction was recorded in any
group at 48 h after administration. T. citrina was safe up to a
dose level of 3200 mg/kg body weight.
3.3. Subacute toxicity test
3.3.1. Effect on body weight
Body weight was determined on day 0, 9th, 18th and 28th
days. The body weight of rat in control group showed gradual
increase during the 28th day's treatment period up to
[(140.20 ± 5.31) g] of weight gain. In contrast administration of
extract at 250, 500 and 1000 mg/kg per day doses showed
respectively, [(143.40 ± 6.15), (137.50 ± 6.11) and
(130.90 ± 4.86) g] increase in body weight (Table 1).
3.3.2. Effect on relative weight of liver and kidney
The intact weight of liver and kidney was converted to
relative weight of 100 g body weight as shown in Table 2. The
result showed that extract in different doses (250, 500 and
1000 mg/kg per day) administered for 28 days has non-
signiﬁcant effect on liver and kidney weight compared to
vehicle control.
3.3.3. Effect on hematological parameters
The effect of extracts on hematological indices was examined
at the end of treatment (Table 3). Treatment for 28 days has non-
signiﬁcant effect on WBC, RBC, platelet count, Hb, neutrophil,
lymphocyte, monocyte, eosinophil, hematocrit, MPV, PDW,
ESR, BT and CT. At 1000 mg/kg per day dose MCH show
signiﬁcant (P < 0.05) while MCV and MCHC at same con-
centration showed (P < 0.001) compared to control (Table 3).rent days (g).
Weight
18th day 28th day
131.10 ± 5.75 140.20 ± 5.31
ns 134.70 ± 6.28ns 143.40 ± 6.15ns
ns 127.40 ± 6.59ns 137.50 ± 6.11ns
ns 122.90 ± 4.54ns 130.90 ± 4.86ns
ІІІ: 1000 mg/kg); ns: Not signiﬁcant.
Table 3



















Control 5.9 ± 0.4 6.6 ± 0.1 540.5 ± 17.5 11.7 ± 0.1 1.2 ± 0.1 4.6 ± 0.3 0.1 ± 0.1 0.1 ± 0.1 37.7 ± 0.5
І 5.3 ± 0.4n.s. 6.9 ± 0.1n.s. 541.0 ± 22.1n.s. 11.9 ± 0.1n.s. 0.9 ± 0.1n.s. 4.2 ± 0.3n.s. 0.1 ± 0.1n.s. 0.1 ± 0.1n.s. 38.2 ± 0.4n.s.
ІІ 5.2 ± 0.4n.s. 6.6 ± 0.1n.s. 490.5 ± 13.8n.s. 11.5 ± 0.3n.s. 0.9 ± 0.1n.s. 4.2 ± 0.3n.s. 0.1 ± 0.1n.s. 0.1 ± 0.1n.s. 36.3 ± 0.4n.s.
ІІІ 5.9 ± 0.4n.s. 6.8 ± 0.1n.s. 535.0 ± 20.1n.s. 11.7 ± 0.1n.s. 1.1 ± 0.1n.s. 4.7 ± 0.3n.s. 0.1 ± 0.1n.s. 0.1 ± 0.1n.s. 36.8 ± 0.3n.s.
MCV (fL) MCH (pg) MCHC (g/dL) RDW (%) MPV (fL) PDW (%) ESR (Mm/h) Bleeding time (sec) Clotting time (min)
56.9 ± 0.2 17.5 ± 0.1 31.1 ± 0.2 13.9 ± 0.3 4.1 ± 0.1 16.1 ± 0.1 2.1 ± 0.1 34.5 ± 2.2 4.1 ± 0.1
55.3 ± 0.2a 17.2 ± 0.1n.s. 31.6 ± 0.1a 12.7 ± 0.2b 4.1 ± 0.1n.s. 16.5 ± 0.2n.s. 2.2 ± 0.1n.s. 37.5 ± 2.5n.s. 4.1 ± 0.1n.s.
54.1 ± 0.3c 17.1 ± 0.1a 31.7 ± 0.1b 12.5 ± 0.1c 4.1 ± 0.1n.s. 16.4 ± 0.2n.s. 2.2 ± 0.1n.s. 37.5 ± 2.5n.s. 4.1 ± 0.1n.s.
54.1 ± 0.5c 17.1 ± 0.1a 31.7 ± 0.1b 12.5 ± 0.1c 4.1 ± 0.1n.s. 16.1 ± 0.1n.s. 2.2 ± 0.1n.s. 37.5 ± 2.5n.s. 4.1 ± 0.1n.s.
Groups І–ІІІ methanolic extracts with doses (І: 250 mg/kg; ІІ: 500 mg/kg; ІІІ: 1000 mg/kg); BT: Bleeding time; CT: Clotting time; n.s.: Not signiﬁcant;
a:P < 0.05; b:P < 0.01; c:P < 0.001.
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The effect of extracts for 28 days doesn't showed signiﬁcant
creatinine, urea, uric acid, total protein and albumin at doses
250, 500 and 1000 mg/kg per day compare to control (Table 4).Table 4
Effect of methanol extract of T. citrina leaves for 28-day treatment on bioch
Group Creatinine (mg/dL) Urea (mg/dL) Uric
Control 0.87 ± 0.03 6.08 ± 0.12 3
І 0.86 ± 0.03ns 5.97 ± 0.08ns 3
ІІ 0.84 ± 0.03ns 5.91 ± 0.12ns 2
ІІІ 0.86 ± 0.03ns 5.89 ± 0.11ns 3
Groups І–ІІІ methanolic extracts with doses (І: 250 mg/kg; ІІ: 500 mg/kg;
Figure 1. Photomicrograph of rat liver treated with different doses of extracts
A: Control group; B: T. citrina (250 mg/kg per day) group; C: T. citrina (500
normal liver histology.3.3.5. Histology of liver and kidney
Light microscopic examination of liver and kidney sections
of the control group showed a normal histology of liver and
kidney. Similarly, extracts with all three doses 250, 500 andemical parameter of rats.
acid (mg/dL) Total protein (g/dL) Albumin (g/dL)
.06 ± 0.11 6.16 ± 0.12 3.83 ± 0.13
.08 ± 0.14ns 6.19 ± 0.15ns 3.77 ± 0.18ns
.85 ± 0.14ns 5.95 ± 0.15ns 3.69 ± 0.15ns
.01 ± 0.16ns 6.24 ± 0.16ns 3.83 ± 0.17ns
ІІІ: 1000 mg/kg); ns: Not signiﬁcant.
for 28 days.
mg/kg per day) group; D: T. citrina (1000 mg/kg per day) group showing
Figure 2. Photomicrograph of rat kidney treated with different doses of T. citrina for 28 days.
A: Control group; B: T. citrina (250 mg/kg per day) group; C: T. citrina (500 mg/kg per day) group; D: T. citrina (1000 mg/kg per day) group showing
normal kidney histology.
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histological features of rat liver and kidney (Figures 1 and 2).
4. Discussion
Due to negligible adverse effects, natural compounds take an
important role in therapeutic applications. However, there is a
lack of scientiﬁc validation on the toxicity and adverse effects of
these natural compounds. Therefore, scientiﬁc knowledge to-
wards acute oral toxicity study is much needed, which will not
only help identify the range and concentration of dose that could
be used subsequently, but also to reveal the possible clinical
signs elicited by the substances under investigation. In addition,
it is also a useful parameter to investigate the therapeutic index
of drugs and xenobiotics[21]. In our work, the phytochemical
analysis of methanol extracts of T. citrina was carried out.
The methanolic extract contained alkaloids, ﬂavonoids,
tannins, reducing sugar and carbohydrates.
After 28 days treatment of methanolic extract of T. citrina
leaves, there were no signiﬁcant changes in weight of body and
organs. All the animals exhibited a normal increment in body
weight without drastic difference between both control and
treated groups.
The haematological parameters between control and treated
groups, showed that the extract was not toxic to circulating red
cells, nor interfered with the production and that of platelets. The
haematopoietic system is one of the most sensitive targets of
toxic compounds and is an important index of physiological and
pathological status in man and animals[22]. The RBC indices,
MCV, MCH and MCHC showed marginal decrease in the
extract treated compared to the control. The importance of
calculated blood indices in anemia diagnosis has been
reported[23]. The non-signiﬁcant difference on the RBC indicessuggested that the extract did not affect a change in the
average size of RBCs. By extension, it did not induce anemia.
There was also, notably no change in WBC count which is
known to rise as body defense in response to toxic
environment[24]. On the other hand, lymphocyte, the main
effector's cell of the immune system[25] recorded ﬂuctuation
suggesting that the extract might not have exerted challenge
on the immune system of the animals.
In addition, most of the biochemical parameters were not
also altered by the methanol extract of T. citrina. The lack of
signiﬁcant alterations in the levels of alanine aminotransferase,
aspartate amino transferase, alkaline phosphatase, glucose and
creatinine, which are good indicators of liver and kidney
functions, suggests that sub-chronic administration of extract
neither altered hepatocytes and kidneys of rats nor the normal
metabolism of the animals[26]. Because these clinical blood
chemical parameters are the index of kidney and liver
function, it suggests that the extract does not induce toxicity
to the kidneys and liver. These observations were further
conﬁrmed by the histological assessment of the organs
showed in Figures 1 and 2. Some of the species of Termi-
nalia genus such as Terminalia chebula, Terminalia belerica,
Terminalia arjuna, Terminalia mollis, Terminalia avi-
cennioides and Terminalia paniculata have been previously
reported to exhibit similar activities and have been used as
good therapeutic agents[27–32]. Based on the results found in our
study, we concluded that T. citrina methanol extract was safer
and non toxic and could be well used for pharmacological and
therapeutic purposes.
In conclusion, the present results show that methanol extract
of leaves of T. citrina does not cause any apparent in vivo
toxicity in an animal model. No death or signs of toxicity were
observed in rat treated with extract at doses 250, 500 and
Narhari Das et al./Journal of Acute Disease 2015; 4(4): 316–321 3211000 mg/kg body weight, thus its safety in use. The histology
examination revealed no changes in the architecture of the in-
ternal organs kidney and liver of rat, in both control and treated
groups. Hence, leaves of T. citrina can be used as a medicinal
agent in known dosages, especially in rural communities where
conventional drugs are unaffordable because of their cost. A
detailed experimental analysis of its chronic toxicity is essential
for further support of this plant.
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